Once‐Weekly Subcutaneous Delivery of Polymer‐Linked Rotigotine ( SER ‐214) Provides Continuous Plasma Levels in Parkinson's Disease Patients-Reference-Cited by-同舟云学术

Once‐Weekly Subcutaneous Delivery of Polymer‐Linked Rotigotine ( SER ‐214) Provides Continuous Plasma Levels in Parkinson's Disease Patients

Published:2020-04-06 Issue:6 Volume:35 Page:1055-1061
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Olanow C. Warren¹²,Standaert David G.³^ORCID,Kieburtz Karl²⁴,Viegas Tacey X.⁵,Moreadith Randall⁵

Affiliation:

1. Departments of Neurology and NeuroscienceMount Sinai School of Medicine New York New York USA

2. Clintrex Research Corporation Sarasota Florida USA

3. Department of NeurologyUniversity of Alabama Birmingham Alabama USA

4. Department of NeurologyUniversity of Rochester Rochester New York USA

5. Serina Therapeutics, Inc. Huntsville Alabama USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28027

Reference22 articles.

1. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications

2. Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

3. Role of High-Affinity Dopamine Uptake and Impulse Activity in the Appearance of Extracellular Dopamine in Striatum After Administration of Exogenous L-DOPA. Studies in Intact and 6-Hydroxydopamine-Treated Rats

4. Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates

5. Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U‐91356A) in MPTP‐exposed monkeys;Blanchet PJ;J Pharmacol Exp Ther,1995

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine agonists in the treatment of Parkinson's disease: the show must go on;Journal of Neural Transmission;2024-09-11

2. Recent developments in synthetic approaches for macromolecular prodrugs;Progress in Polymer Science;2024-08

3. Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation;Frontiers in Drug Delivery;2024-04-26

4. Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure;Science Advances;2024-04-19

5. Determination of ω -end functionalities in tailored poly(2-alkyl-2-oxazoline)s by liquid chromatography and mass spectrometry;Royal Society Open Science;2024-02